About CEDAR
CEDAR is a post-market open-ended global registry to assess clinical outcomes of the Castor™ or Cratos™ Branched Aortic Stent Graft Systems for endovascular repair of thoracic aortic pathology in a real-world population. All patients in this study are treated with Castor™ or Cratos™ and this study is designed to capture outcomes in a formalised system.
The Castor™ and Cratos™ branched aortic stent grafts are the first branched stent grafts specifically designed for the aortic arch, with a single branch extending into the LSA and no requirement for adjunctive surgical procedures. Multiple clinical centres around the world will be involved to include a broad range of experience in a wide geographical span.
Enrolment will be open-ended and of eligible patients undergoing treatment with the Castor™ or Cratos™ system at each site. All subjects will be followed procedurally to discharge and according to institutional standard of care to 5-years post implant.
It is intended that studying a real-world patient population in a multi-centre setting will provide important information on both the treatment approach and system.
